RxDoctor Payments Data

Tracy Capes, MD

Urogynecology and Reconstructive Pelvic Surgery · West Allis, WINPI 1740448828

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 65.0% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in WI, where the typical reported total is $3,148.

$2,953in general payments, 2019–2025

Across 37 payments — averaging $79.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$657
  • Axonics, Inc.$376
$11,777in research payments, 2019–2025

Across 12 payments — averaging $981.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$5K
  • AbbVie$3K
  • Medtronic$3K

What the payments were for

  • Food & beverage$2,953100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific24$1,920
Medtronic(2 entities)8$657
Axonics, Inc.5$376

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,953 in reported general payments places this provider in the 40th percentile of 25 urogynecology and reconstructive pelvic surgery providers in Wisconsin.

See all urogynecology and reconstructive pelvic surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$98,454
Medicare patients
319
Services billed
2,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron410$346,610
GemtesaVibegron87$59,949
Estradiol259$15,253
Trospium Chloride ErTrospium Chloride97$10,109
Trospium Chloride140$8,581
Mirabegron ErMirabegron11$8,215
Methenamine Hippurate74$6,292
Fesoterodine Fumarate ErFesoterodine Fumarate18$2,949
Solifenacin Succinate63$2,739
Trimethoprim47$2,025
Cefdinir140$1,725
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst53$600
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim154$544
Amitriptyline Hcl33$454
Ibuprofen70$324

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in West Allis

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →